Protagenic Therapeutics (PTIX) Stock Chart & Stock Price History → “Dollar Will Be Worth NOTHING” -Musk (From Crypto 101 Media) (Ad) Free PTIX Stock Alerts $1.34 -0.15 (-10.07%) (As of 05/17/2024 ET) Add Compare Share Share ChartStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial Media Protagenic Therapeutics Stock Price Performance5 Day Performance+11.52%1 Month Performance+11.12%3 Month Performance+50.03%6 Month Performance+76.50%Year-To-Date Performance+51.53%1 Year Performance-24.62% Receive PTIX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Protagenic Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Crypto 101 Media[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Are you monitoring 13,217 cryptocurrencies everyday? If not, you could miss the ONE that can make you wealthy beyond your wildest dreams. You see, while Bitcoin and Ethereum steal all the headlines… It’s often the cryptos flying under the radar that turn small stakes into life-changing windfalls. Claim your free seat by clicking here now. PTIX Stock Chart for Friday, May, 17, 2024 PTIX Chart by TradingView Protagenic Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/16/2024$1.33$1.49+12.03%$1.49$1.301,413 shs$6.61 million05/15/2024$1.25$1.33+6.40%$1.40$1.314,819 shs$5.90 million05/14/2024$1.35$1.25-7.08%$1.28$1.229,673 shs$5.55 million05/13/2024$1.35$1.35$1.35$1.3569 shs$5.97 million05/10/2024$1.29$1.35+4.28%$1.35$1.32870 shs$5.97 million05/09/2024$1.24$1.29+3.95%$1.33$1.25709 shs$5.73 million Get the Latest News and Ratings for PTIX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Protagenic Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/08/2024$1.22$1.24+1.72%$1.24$1.221,580 shs$5.51 million05/07/2024$1.25$1.22-2.40%$1.28$1.223,043 shs$5.42 million05/06/2024$1.28$1.25-2.34%$1.33$1.252,819 shs$5.55 million05/03/2024$1.30$1.28-1.54%$1.34$1.281,837 shs$5.68 million05/02/2024$1.30$1.30$1.38$1.251,529 shs$5.77 million05/01/2024$1.38$1.30-5.58%$1.34$1.30980 shs$5.77 million04/30/2024$1.41$1.38-2.35%$1.38$1.273,566 shs$6.11 million04/29/2024$1.39$1.41+1.81%$1.47$1.324,615 shs$6.26 million04/26/2024$1.57$1.46-6.93%$1.48$1.3210,467 shs$6.48 million04/25/2024$1.59$1.57-1.34%$1.60$1.3016,676 shs$6.97 million04/24/2024$1.57$1.59+1.27%$1.70$1.316,507 shs$7.06 million04/23/2024$1.25$1.57+25.60%$1.80$1.3071,302 shs$6.97 million04/22/2024$1.29$1.25-3.10%$1.34$1.257,533 shs$5.55 million04/19/2024$1.37$1.29-5.84%$1.39$1.254,290 shs$5.73 million04/18/2024$1.35$1.37+1.48%$1.52$1.375,824 shs$6.08 million04/17/2024$1.35$1.35$1.36$1.151,315 shs$5.99 million04/16/2024$1.40$1.35-3.39%$1.42$1.342,181 shs$5.99 million04/15/2024$1.44$1.40-2.97%$1.44$1.351,887 shs$6.20 million04/12/2024$1.64$1.44-12.20%$1.79$1.449,748 shs$6.39 million04/11/2024$1.63$1.64+0.61%$1.65$1.643,288 shs$7.28 million04/10/2024$1.57$1.63+4.15%$1.63$1.522,628 shs$7.24 million04/09/2024$1.53$1.57+2.29%$1.60$1.465,720 shs$6.95 million04/08/2024$1.61$1.53-4.97%$1.66$1.531,593 shs$6.79 million04/05/2024$1.65$1.64-0.61%$1.67$1.5227,230 shs$7.28 million04/04/2024$1.64$1.65+0.61%$1.73$1.5411,425 shs$7.33 million04/03/2024$1.69$1.64-2.96%$1.65$1.562,991 shs$7.28 million04/02/2024$1.74$1.69-2.87%$1.79$1.429,461 shs$7.50 million04/01/2024$1.75$1.74-0.57%$1.75$1.705,691 shs$7.73 million03/29/2024$1.75$1.75$1.84$1.689,049 shs$7.77 million03/28/2024$1.82$1.75-3.85%$1.84$1.688,914 shs$7.77 million03/27/2024$1.75$1.82+4.00%$1.87$1.5132,673 shs$8.08 million03/26/2024$1.69$1.75+3.55%$1.86$1.5928,145 shs$7.77 million03/25/2024$1.55$1.69+9.03%$1.74$1.368,697 shs$7.50 million03/22/2024$1.43$1.55+8.39%$1.58$1.3811,583 shs$6.88 million41 banks launch ‘crypto dollar’ (Ad)Everyone knows the US financial system is in the middle of a radical change... The White House wants an all-digital dollar. Plus at least 41 major banks (see if your bank is one of them right here).Here's how you capitalize (including #1 crypto to play it).03/21/2024$1.35$1.43+5.93%$1.61$1.3719,911 shs$6.35 million03/20/2024$1.30$1.35+4.25%$1.45$1.3044,439 shs$5.99 million03/19/2024$1.20$1.30+7.92%$1.48$1.2456,803 shs$5.75 million03/18/2024$1.15$1.20+4.35%$1.22$1.202,594 shs$5.33 million03/15/2024$1.10$1.15+4.55%$1.24$1.1318,275 shs$5.11 million03/14/2024$1.11$1.10-0.90%$1.33$1.0514,383 shs$4.88 million03/13/2024$1.08$1.11+2.78%$1.19$1.1110,336 shs$4.93 million03/12/2024$1.13$1.08-4.42%$1.13$1.013,965 shs$4.79 million03/11/2024$1.10$1.13+2.73%$1.15$1.133,988 shs$5.02 million03/08/2024$1.03$1.10+6.38%$1.15$1.0010,129 shs$4.88 million03/07/2024$1.06$1.03-2.45%$1.11$1.013,196 shs$4.59 million03/06/2024$1.16$1.06-8.62%$1.25$1.0218,121 shs$4.71 million03/05/2024$1.00$1.16+16.00%$1.40$1.0593,148 shs$5.15 million03/04/2024$1.00$1.00-0.01%$1.09$1.002,623 shs$4.44 million03/01/2024$1.05$1.05$1.09$0.895,387 shs$4.66 million02/29/2024$0.97$1.05+8.36%$1.07$0.888,237 shs$4.66 million02/28/2024$0.88$0.97+10.11%$0.97$0.895,451 shs$4.30 million02/27/2024$0.88$0.88$0.89$0.881,998 shs$3.90 million02/26/2024$0.89$0.88-0.73%$0.88$0.88465 shs$3.91 million02/23/2024$0.98$0.89-9.55%$0.98$0.881,636 shs$3.94 million02/22/2024$1.01$0.98-2.96%$1.01$0.947,234 shs$4.35 million02/21/2024$1.00$1.01+1.00%$1.05$1.0015,993 shs$4.48 million02/20/2024$1.00$1.00+0.01%$1.09$1.006,613 shs$4.44 million02/19/2024$1.00$1.00$1.00$0.975,700 shs$4.44 million02/16/2024$0.97$1.00+3.62%$1.00$0.975,754 shs$4.44 million Related Companies: Sonnet BioTherapeutics Stock Price Chart Genprex Stock Price Chart Yumanity Therapeutics Stock Price Chart Hoth Therapeutics Stock Price Chart Lipella Pharmaceuticals Stock Price Chart Adial Pharmaceuticals Stock Price Chart Kineta Stock Price Chart Synaptogenix Stock Price Chart Lixte Biotechnology Stock Price Chart Enveric Biosciences Stock Price Chart Receive PTIX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Protagenic Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:PTIX) was last updated on 5/17/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportWhy Is Gold On a MASSIVE rally? Huge AlertsGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchDems have chosen Biden replacement?Paradigm PressCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingShocking $16T Elon Musk Crypto LeakCrypto 101 MediaThe #1 Investment of the Decade… Porter & Company[URGENT] DO NOT Touch These AI Stocks!Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Protagenic Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.